Loading...
MVC logo

Metrovacesa S.A.Informe acción BME:MVC

Capitalización bursátil €1.6b
Precio de las acciones
€10.70
€10.81
1.0% infravalorado descuento intrínseco
1Y-2.3%
7D-11.3%
1D
Valor de la cartera
Ver

Metrovacesa S.A.

Informe acción BME:MVC

Capitalización de mercado: €1.6b

MVC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Competidores de Metrovacesa S.A.

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del Metrovacesa
Precios históricos de las acciones
Precio actual de la acción€10.70
Máximo en las últimas 52 semanas€13.50
Mínimo de 52 semanas€8.82
Beta0.71
Cambio en 1 mes-9.01%
Variación en 3 meses-2.28%
Cambio de 1 año-2.28%
Variación en 3 años53.74%
Variación en 5 años44.79%
Variación desde la OPV-33.13%

Noticias y actualizaciones recientes

Actualización de narrativa May 02

MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside

Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.
Actualización de narrativa Apr 17

MVC: Higher Required Return And Rich P/E Will Pressure Future Returns

Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.
Actualización de narrativa Apr 03

MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns

Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.

Recent updates

Actualización de narrativa May 02

MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside

Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.
Actualización de narrativa Apr 17

MVC: Higher Required Return And Rich P/E Will Pressure Future Returns

Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.
Actualización de narrativa Apr 03

MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns

Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.
Actualización de narrativa Mar 20

MVC: Dividend Outlook And Revised Assumptions Will Shape Future Return Balance

Analysts now set their fair value estimate for Metrovacesa at €10.81 per share, up from €10.63. This reflects updated assumptions around the discount rate, revenue growth, profit margin and future P/E.
Actualización de narrativa Mar 06

MVC: Lower Growth Assumptions And Elevated P/E Will Sustain Bearish View

Analysts have modestly lowered their price target on Metrovacesa to €9.30, citing updated assumptions for revenue growth, profit margins and the future P/E multiple, while keeping their fair value estimate unchanged at €9.30. Valuation Changes Fair Value: The fair value estimate is unchanged at €9.30 per share, indicating no revision to the overall valuation outcome.
Actualización de narrativa Feb 20

MVC: Dividend Outlook And Updated Assumptions Will Shape Future Return Balance

Analysts have slightly trimmed their fair value estimate for Metrovacesa from €10.83 to €10.63, citing updated assumptions around discount rates, expected revenue growth, margins and future P/E levels. Valuation Changes Fair Value: Trimmed slightly from €10.83 to €10.63 per share.
Actualización de narrativa Feb 06

MVC: Lower Discount Rate And High P/E Will Sustain Bearish View

Analysts have slightly raised their price target on Metrovacesa, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E, which together indicate a modestly higher fair value per share in euro terms. Valuation Changes Fair Value: unchanged at €9.30 per share.
Actualización de narrativa Jan 23

MVC: Dividend Reserve Plans And P/E Revisions Will Guide Cautious Outlook

Analysts have maintained their Metrovacesa fair value target at €9.30, citing a combination of updated assumptions that include slightly lower discount rates, higher revenue growth expectations, softer profit margins and a higher future P/E multiple in their latest models. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments).
Actualización de narrativa Jan 08

MVC: Dividend Proposal At Extraordinary Meeting Will Support Bullish Thesis

Analysts have revised their price target on Metrovacesa from €11.80 to €13.10, citing updated assumptions around discount rates, revenue growth, profit margins, and the future P/E multiple. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (calle principe de vergara 187, plaza de rodrigo uria, madrid) (Key Developments) The meeting agenda includes a proposal to discuss the distribution of dividends from freely distributable reserves, which may be relevant if you are focusing on potential cash returns to shareholders (Key Developments) The notice also refers to discussion of other matters at the meeting, indicating that additional shareholder topics could be addressed beyond dividends (Key Developments) Valuation Changes Fair Value Estimate was revised from €11.80 to €13.10, indicating a higher assessed value per share.
Actualización de narrativa Dec 24

MVC: Dividend Reserve Plans Will Shape A Cautious Medium-Term Outlook

Analysts have raised their price target on Metrovacesa from €6.50 to €9.30, citing higher expected revenue growth, improved profit margins, and a modestly richer future P/E multiple, despite a slightly higher discount rate. What's in the News Metrovacesa has called a special shareholders meeting for November 25, 2025, at 13:00 CET in Madrid to address key corporate matters.
Artículo de análisis Dec 20

Metrovacesa S.A. (BME:MVC) Shares Could Be 23% Below Their Intrinsic Value Estimate

Key Insights Metrovacesa's estimated fair value is €11.52 based on 2 Stage Free Cash Flow to Equity Current share price...
Actualización de narrativa Dec 10

MVC: Dividend Decision And Revised Outlook Will Shape Balanced Return Prospects

Analysts have raised their price target on Metrovacesa from €9.81 to €10.83, citing a higher long term fair value despite moderating assumptions for revenue growth, profit margins and future earnings multiples. What's in the News Metrovacesa has scheduled a special and extraordinary shareholders meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments) The main agenda item for the upcoming meeting is the potential distribution of dividends from freely distributable reserves, which could affect shareholder returns policy (Key Developments) Shareholders will also address other unspecified matters at the meeting, leaving scope for additional corporate or capital structure decisions (Key Developments) Valuation Changes Fair Value: raised slightly from €9.81 to €10.83 per share, reflecting a modest uplift in long term valuation.
Artículo de análisis Oct 02

Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Metrovacesa S.A. ( BME:MVC ), is not the largest company out there, but it had a relatively subdued couple of weeks in...
Artículo de análisis Jul 25

Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €12.58 Metrovacesa's €10.15...
Artículo de análisis May 04

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Artículo de análisis Apr 12

Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Key Insights The projected fair value for Metrovacesa is €16.96 based on 2 Stage Free Cash Flow to Equity Metrovacesa...
Artículo de análisis Feb 26

Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest

Even though Metrovacesa S.A.'s ( BME:MVC ) recent earnings release was robust, the market didn't seem to notice. We...
User avatar
Nueva narrativa Feb 19

Will Leverage Undersupplied Spanish Housing Market For Future Opportunities

High presales coverage allows focus on margin maximization, boosting future net margins amid an undersupplied market.
Artículo de análisis Feb 07

Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it maintained its current share price...
Artículo de análisis Dec 13

An Intrinsic Calculation For Metrovacesa S.A. (BME:MVC) Suggests It's 44% Undervalued

Key Insights Metrovacesa's estimated fair value is €16.39 based on 2 Stage Free Cash Flow to Equity Metrovacesa's €9.13...
Artículo de análisis Sep 12

Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights The projected fair value for Metrovacesa is €9.93 based on 2 Stage Free Cash Flow to Equity Metrovacesa's...
Artículo de análisis Aug 01

We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

The subdued stock price reaction suggests that Metrovacesa S.A.'s ( BME:MVC ) strong earnings didn't offer any...
Artículo de análisis Jul 17

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it saw significant share price...
Artículo de análisis May 28

A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €9.31 Current share price...
Artículo de análisis May 01

We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis Mar 27

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it received a lot of attention from a...
Artículo de análisis Feb 12

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights The projected fair value for Metrovacesa is €9.08 based on 2 Stage Free Cash Flow to Equity Current share...
Artículo de análisis Nov 05

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis Jul 05

These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Artículo de análisis May 21

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it saw significant share...
Artículo de análisis Apr 19

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €7.36 Current share price...
Artículo de análisis Dec 02

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis Sep 23

Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it received a lot of...
Artículo de análisis May 19

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Does the May share price for Metrovacesa S.A. ( BME:MVC ) reflect what it's really worth? Today, we will estimate the...
Artículo de análisis Mar 05

Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality

Metrovacesa S.A. ( BME:MVC ) just reported healthy earnings but the stock price didn't move much. We think that...
Artículo de análisis Feb 16

Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Artículo de análisis Oct 05

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis Jul 02

Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?

Today we will run through one way of estimating the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by projecting its...
Artículo de análisis May 06

Is Metrovacesa (BME:MVC) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis Apr 06

Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?

Is Metrovacesa S.A. ( BME:MVC ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
Artículo de análisis Mar 15

Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years

Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 12% in the last month. But that...
Artículo de análisis Feb 16

Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven

We feel now is a pretty good time to analyse Metrovacesa S.A.'s ( BME:MVC ) business as it appears the company may be...
Artículo de análisis Jan 26

When Should You Buy Metrovacesa S.A. (BME:MVC)?

Metrovacesa S.A. ( BME:MVC ), might not be a large cap stock, but it led the BME gainers with a relatively large price...
Artículo de análisis Jan 05

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

In this article we are going to estimate the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by taking the expected...
Artículo de análisis Dec 14

If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 11% in the last month. But that...

Rentabilidad de los accionistas

MVCES Real EstateMercado ES
7D-11.3%-2.7%1.0%
1Y-2.3%0.1%22.7%

Rentabilidad vs. Industria: MVC igualó a la industria Spanish Real Estate, que obtuvo un rendimiento del 0.1% el año pasado.

Rentabilidad vs. Mercado: MVC obtuvo unos resultados inferiores a los del mercado Spanish, que fueron del 22.7% el año pasado.

Volatilidad de los precios

Is MVC's price volatile compared to industry and market?
MVC volatility
MVC Average Weekly Movement5.6%
Real Estate Industry Average Movement3.9%
Market Average Movement3.9%
10% most volatile stocks in ES Market6.7%
10% least volatile stocks in ES Market0.9%

Precio estable de las acciones: El precio de las acciones de MVC ha sido volátil durante los últimos 3 meses en comparación con el mercado Spanish.

Volatilidad a lo largo del tiempo: La volatilidad semanal de MVC(6%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de Spanish.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1918214Jorge de Leza Eguigurenwww.metrovacesa.com

Metrovacesa S.A. opera como promotora inmobiliaria en España. La empresa promueve y vende locales residenciales y comerciales, además de vender terrenos. Metrovacesa S.A. se fundó en 1918 y tiene su sede en Madrid, España.

Resumen de fundamentos de Metrovacesa S.A.

¿Cómo se comparan los beneficios e ingresos de Metrovacesa con su capitalización de mercado?
Estadísticas fundamentales de MVC
Capitalización bursátil€1.62b
Beneficios(TTM)€56.86m
Ingresos (TTM)€708.37m
28.5x
Ratio precio-beneficio (PE)
2.3x
Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de MVC
Ingresos€708.37m
Coste de los ingresos€528.83m
Beneficio bruto€179.54m
Otros gastos€122.68m
Beneficios€56.86m

Últimos beneficios comunicados

Dec 31, 2025

Próxima fecha de beneficios

Jul 22, 2026

Beneficios por acción (BPA)0.38
Margen bruto25.35%
Margen de beneficio neto8.03%
Ratio deuda/patrimonio30.7%

¿Cómo se ha desempeñado MVC a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

14.8%
Rentabilidad actual por dividendo
n/a
Ratio de pagos
¿Cuándo hay que comprar MVC para recibir un próximo dividendo?
fechas de dividendos de Metrovacesa
Fecha ex dividendoMay 20 2026
Fecha de pago de dividendosMay 22 2026
Días hasta ex dividendo2 days
Días hasta la fecha de pago de dividendos0 days

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/21 06:07
Precio de las acciones al final del día2026/05/21 00:00
Beneficios2025/12/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Metrovacesa S.A. está cubierta por 22 analistas. 2 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Ignacio RomeroBanco de Sabadell. S.A.
null nullBanco de Sabadell. S.A.
Mariano Miguel HidalgoBanco Santander